Long-Term Clinical Results of Ab-Interno Trabeculotomy in Glaucoma Management
Glaucoma is one of the leading causes of irreversible vision loss worldwide. Elevated intraocular pressure (IOP) is the most important risk factor for the development and progression of the disease.
Ab-interno trabeculotomy (AIT) using the Trabectome system is a minimally invasive glaucoma surgery (MIGS) that reduces aqueous humor outflow resistance by ablating the trabecular meshwork and the inner wall of Schlemm's canal, thereby lowering intraocular pressure.
Previous studies have demonstrated good short-term efficacy of this procedure. However, robust long-term data spanning several years remain scarce.
The aim of this study is to evaluate the long-term outcomes of AIT in glaucoma patients who underwent surgery between 2019 and 2021 at the Department of Ophthalmology, University Hospital Würzburg. Patients are invited for a single study visit at which intraocular pressure, visual acuity, anterior chamber angle by gonioscopy, and optic nerve structure by optical coherence tomography (OCT) are assessed. The collected data are compared with pre-operative baseline values obtained from medical records.
The results are intended to improve the assessment of long-term surgical success and to optimize patient selection for this procedure in the future.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Glaucoma is a progressive optic neuropathy in which elevated intraocular pressure (IOP) represents the primary modifiable risk factor. Ab-interno trabeculotomy (AIT) with the Trabectome is a minimally invasive glaucoma surgery (MIGS) that reduces IOP by ablating the trabecular meshwork and inner wall of Schlemm's canal, thereby improving aqueous humor outflow.
Previous studies have demonstrated favorable short-term IOP reduction and a good safety profile. However, robust long-term data evaluating sustained surgical success, disease progression, and the need for additional interventions over multiple years are currently lacking.
This single-center, observational study with a retrospective pre-operative baseline and a prospective cross-sectional follow-up visit addresses this knowledge gap. Patients who underwent AIT at the Department of Ophthalmology, University Hospital Würzburg, are contacted and invited for a single study visit of approximately 30 minutes.
At this visit, the following assessments are performed:
- Medical history review since the time of surgery
- Visual acuity assessment
- Goldmann applanation tonometry (IOP measurement)
- Slit-lamp biomicroscopy including gonioscopy for the anterior chamber angle
- Optical coherence tomography (OCT) of the optic nerve head and retinal nerve fiber layer (RNFL)
All examinations are non-invasive, painless, and consistent with routine ophthalmic care. No additional follow-up visits are required beyond this single study contact.
Pre-operative data, including baseline IOP, glaucoma diagnosis, medication use, and surgical details are obtained from existing medical records. These are compared with findings at the study visit to evaluate long-term treatment success.
The study is initiated and funded by the Department of Ophthalmology, University Hospital Würzburg. No external funding or industry sponsorship is involved. The study has been approved by the responsible Ethics Committee with no objections raised.
Approximately 180 participants are planned for enrollment. Data are pseudonymized and stored on password-protected servers. No data transfer to third parties or outside the European Union is performed. Data will be deleted no later than 10 years after study completion.
Tipo de estudio
Inscripción (Estimado)
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Raoul Verma-Führing, Dr.
- Número de teléfono: +49 931 20120458
- Correo electrónico: augenklinik@ukw.de
Copia de seguridad de contactos de estudio
- Nombre: Eric Schreiner
- Correo electrónico: ericschreiner03studium@gmail.com
Ubicaciones de estudio
-
-
Bavaria
-
Würzburg, Bavaria, Alemania, 97080
- Reclutamiento
- University Hospital Würzburg
-
Contacto:
- Raoul Verma-Führing
- Número de teléfono: +49 931 20120351
- Correo electrónico: augenklinik@ukw.de
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Método de muestreo
Población de estudio
Descripción
Inclusion Criteria:
- Diagnosis of glaucoma
- Previous ab-interno trabeculotomy (AIT) using the Trabectome device performed at the Department of Ophthalmology, University Hospital Würzburg
- Surgery performed between 2019 and 2021
- Ability to provide written informed consent
- Age ≥ 18 years at time of surgery
Exclusion Criteria:
- Inability to attend the study visit
- Withdrawal of informed consent
- Insufficient medical records for pre-operative baseline data retrieval
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
Cohortes e Intervenciones
Grupo / Cohorte |
Intervención / Tratamiento |
|---|---|
|
AIT Cohort
Tha AIT cohort consists of glaucoma patients who previously underwent ab-interno trabeculotomy (AIT) using the Trabectome device at the Department of Ophthalmology, University Hospital Würzburg.
Participants are invited for a single follow-up visit to assess long-term intraocular pressure control, visual acuity, optic nerve status (OCT), and visual field outcomes compared to pre-operative baseline data obtained from medical records.
|
Ab-interno trabeculotomy (AIT) is a minimally invasive glaucoma surgery (MIGS) performed using the Trabectome device.
The procedure ablates the trabecular meshwork and the inner wall of Schlemm's canal via an ab-interno approach, thereby reducing resistance to aqueous humor outflow and lowering intraocular pressure.
The surgery is performed under local or general anesthesia and can be combined with cataract surgery.
In this observational study, the intervention was performed prior to study enrollment; no surgical intervention is performed as part of the study itself.
Otros nombres:
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Intraocular Pressure (IOP) from Pre-operative Baseline to Follow-up
Periodo de tiempo: From pre-operative baseline to single follow-up visit (minimum 4 years, up to 10 years post-surgery)
|
Mean intraocular pressure (mmHg) measured by Goldmann applanation tonometry at the study visit, compared to pre-operative baseline IOP obtained from medical records.
Surgical success is defined as IOP reduction of ≥20% from baseline and/or IOP ≤18 mmHg, with or without anti-glaucomatous medication.
|
From pre-operative baseline to single follow-up visit (minimum 4 years, up to 10 years post-surgery)
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Number of Intraocular Pressure-Lowering Medications from Pre-operative Baseline to Follow-up
Periodo de tiempo: From pre-operative baseline to single follow-up visit (minimum 4 years, up to 10 years post-surgery)
|
Total number of topical and systemic anti-glaucomatous medications used by the patient at the time of the study visit, compared to the number documented in medical records prior to surgery.
Reduction in medication burden is considered an additional indicator of surgical success.
|
From pre-operative baseline to single follow-up visit (minimum 4 years, up to 10 years post-surgery)
|
|
Visual Acuity at Follow-up
Periodo de tiempo: At single follow-up visit (minimum 4 years, up to 10 years post-surgery)
|
Visual acuity assessed using standardized visual acuity charts at the study visit.
Results are recorded in decimal notation and converted to logMAR for analysis.
Pre-operative VA is obtained from medical records for comparison.
|
At single follow-up visit (minimum 4 years, up to 10 years post-surgery)
|
|
Peripapillary Retinal Nerve Fiber Layer (RNFL) Thickness as Measured by Optical Coherence Tomography (OCT)
Periodo de tiempo: At single follow-up visit (minimum 4 years, up to 10 years post-surgery)
|
Peripapillary RNFL thickness (µm) assessed by spectral- domain optical coherence tomography (SD-OCT) at the study visit.
Global and sectoral RNFL values are recorded.
Results are compared to pre-operative OCT data from medical records where available, to evaluate structural progression of glaucomatous optic neuropathy.
|
At single follow-up visit (minimum 4 years, up to 10 years post-surgery)
|
|
Rate of Surgical Failure Requiring Additional IOP-Lowering Intervention After Ab-Interno Trabeculotomy
Periodo de tiempo: From date of surgery to single follow-up visit (minimum 4 years, up to 10 years post-surgery)
|
Proportion of patients who required additional surgical or laser intervention (e.g., trabeculectomy, tube shunt implantation, selective laser trabeculoplasty) due to insufficient IOP control following AIT.
Data obtained retrospectively from medical records.
Surgical failure is defined as the need for re-intervention at any time point after the primary procedure.
|
From date of surgery to single follow-up visit (minimum 4 years, up to 10 years post-surgery)
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Raoul Verma-Führing, Dr., Wuerzburg University Hospital
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 2025-330-dvha
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .